Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03QTP
|
|||
| Former ID |
DIB004712
|
|||
| Drug Name |
CGP-52411
|
|||
| Synonyms |
DAPH
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Novartis AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H15N3O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4
|
|||
| InChI |
1S/C20H15N3O2/c24-19-15-11-17(21-13-7-3-1-4-8-13)18(12-16(15)20(25)23-19)22-14-9-5-2-6-10-14/h1-12,21-22H,(H,23,24,25)
|
|||
| InChIKey |
AAALVYBICLMAMA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 145915-58-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:53110
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004971) | |||
| REF 2 | Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor. Eur J Cell Biol. 1996 Apr;69(4):327-34. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.